These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3888 related items for PubMed ID: 6166758

  • 1. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Richie JP, Wang BS, Steele GD, Wilson RE, Mannick JA.
    J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
    [Abstract] [Full Text] [Related]

  • 2. Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma.
    Steele G, Wang BS, Richie JP, Ervin T, Yankee R, Mannick JA.
    Cancer; 1981 Mar 15; 47(6):1286-8. PubMed ID: 6164471
    [Abstract] [Full Text] [Related]

  • 3. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA, Dekernion JB, Ramming KP.
    J Urol; 1976 Mar 15; 115(3):243-5. PubMed ID: 1255883
    [Abstract] [Full Text] [Related]

  • 4. Current treatment of metastatic renal cell carcinoma with xenogeneic immune ribonucleic acid.
    Richie JP, Steele GD, Wilson RE, Ervin T, Wang BS, Mannick JA.
    J Urol; 1984 Feb 15; 131(2):236-8. PubMed ID: 6199519
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL, Kern DH, Pilch YH.
    Am J Obstet Gynecol; 1974 Aug 01; 119(7):959-65. PubMed ID: 4135321
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH, Drogemuller CR, Pilch YH.
    Ann N Y Acad Sci; 1976 Aug 01; 276():278-302. PubMed ID: 1071964
    [Abstract] [Full Text] [Related]

  • 12. The therapy of renal adenocarcinoma with immune RNA.
    deKernion JB, Ramming KP.
    Invest Urol; 1980 Mar 01; 17(5):378-81. PubMed ID: 7358501
    [Abstract] [Full Text] [Related]

  • 13. Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
    Märten A, Renoth S, Heinicke T, Albers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Von Ruecker A, Eis-Hübinger AM, Müller S, Schwaner I, Lohmann U, Heylmann G, Sauerbruch T, Schmidt-Wolf IG.
    Hum Gene Ther; 2003 Mar 20; 14(5):483-94. PubMed ID: 12691613
    [Abstract] [Full Text] [Related]

  • 14. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Pilch YH, Veltman LL, Kern DH.
    Arch Surg; 1974 Jul 20; 109(1):30-4. PubMed ID: 4599773
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy.
    Pilch YH, Veltman LL, Kern DH.
    Surgery; 1974 Jul 20; 76(1):23-34. PubMed ID: 4841349
    [No Abstract] [Full Text] [Related]

  • 19. Immunotherapy of renal cell carcinoma.
    deKernion JB.
    Prog Clin Biol Res; 1984 Jul 20; 153():409-21. PubMed ID: 6206509
    [Abstract] [Full Text] [Related]

  • 20. Radio frequency ablation combined with interleukin-2 induces an antitumor immune response to renal cell carcinoma in a murine model.
    Kroeze SG, Daenen LG, Nijkamp MW, Roodhart JM, de Gast GC, Bosch JL, Jans JJ.
    J Urol; 2012 Aug 20; 188(2):607-14. PubMed ID: 22704448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 195.